Mounjaro price hike sparks weight-loss drug crisis
Patients relying on Mounjaro for weight loss face financial strain as prices skyrocket. Experts reveal the alarming consequences of this sudden hike.
Category : Search result: NHS obesity
NHS to roll out revolutionary weight-loss jab Mounjaro
The NHS is set to roll out the groundbreaking weight-loss injection Mounjaro, proven to help patients shed up to 20% of their body weight, as part of a new strategy to tackle obesity.
85% of UK kids not getting enough daily exercise
A concerning report reveals that 85% of UK kids aren't getting enough physical activity, with experts warning of long-term health consequences.
Mounjaro Weight Loss Jab Approved in UK
The UK approves Mounjaro, a groundbreaking weight loss injection, but concerns over its £300 monthly price tag spark debate over NHS accessibility.
Ozempic for Weight Loss: Breakthrough or Risk?
The diabetes drug Ozempic is making waves as a weight-loss solution, but experts urge caution. Discover the pros, cons, and science behind the trend.
Mounjaro maker tackles UK obesity with new programme
The pharmaceutical giant behind Mounjaro unveils an ambitious initiative to combat obesity in the UK, offering hope for millions struggling with weight-related health issues.
NHS to offer weight loss drug Mounjaro
The NHS is set to provide the groundbreaking weight loss medication Mounjaro, produced by Eli Lilly, following successful trials. Shadow Science Secretary Peter Kyle urges swift government action to tackle obesity.
NHS trusts face urgent cost-cutting demands
Dozens of NHS trusts are under pressure to cut costs after the Department of Health and Social Care ordered urgent savings, raising concerns over patient care.
51 Stone Man’s Incredible Weight Loss Journey
A man who once weighed a staggering 51 stone shares his incredible weight loss journey, revealing the struggles and triumphs of battling obesity.
NHS to trial weight loss jab Mounjaro in obesity pilot
The NHS is set to trial the weight loss injection Mounjaro, a drug hailed as a potential game-changer in obesity treatment, as part of a new pilot programme targeting adults struggling with weight issues.
NHS weight loss jabs face postcode lottery
New NHS weight loss injections, including Mounjaro, are being rolled out unevenly, creating a 'postcode lottery' for patients struggling with obesity.
Weight loss jabs may lead to significant regain after stopping
New research suggests that weight loss injections like Wegovy may lead to significant weight regain once discontinued, raising concerns about long-term effectiveness.
NHS to offer weight loss jabs in pharmacies
The NHS is expanding access to obesity treatments Mounjaro and Wegovy, making them available in local pharmacies following approval by NICE.
Weight returns after stopping skinny jabs
New research warns that patients who stop taking weight-loss injections like Wegovy may regain most of the lost weight, raising concerns about long-term effectiveness.
NHS waiting lists hit record 7.57 million
New figures reveal NHS waiting lists have surged to a staggering 7.57 million, with patients facing agonising delays for specialist care. Experts warn the crisis is far from over.
Mounjaro & Ozempic: Weight Loss Breakthrough
New research reveals the surprising long-term benefits of weight loss injections like Mounjaro and Ozempic, offering hope for sustainable obesity management.
NHS faces critical staff shortages in new report
A recent report highlights severe staffing shortages within the NHS, raising concerns over patient care and service sustainability. Experts warn of growing pressures on healthcare workers.
Liver cancer surge in 50s linked to obesity
New data reveals a shocking surge in liver cancer rates among adults in their 50s, with obesity and poor lifestyle choices identified as key culprits. Experts warn of a looming public health disaster.
Weight-loss drug demand 'unsustainable', say pharmacists
UK pharmacists raise alarms over the skyrocketing demand for weight-loss medications, calling it unsustainable and urging for systemic changes.
NHS weight loss campaign faces fat-shaming backlash
A controversial NHS campaign urging people to lose weight sparks backlash, with critics accusing it of fat-shaming and promoting unhealthy body image.
Wegovy Could Save NHS Millions, Study Finds
Groundbreaking research suggests the NHS could save significant costs by prescribing Wegovy for weight loss, reducing obesity-related illnesses.
11-year-old given weight-loss jabs sparks health debate
A mother reveals her heartbreak after discovering her 11-year-old daughter was prescribed weight-loss injections, sparking a debate on childhood obesity treatments.
DNA test predicts childhood obesity risk
A groundbreaking DNA test may soon help identify children at risk of obesity early, offering parents and doctors a chance to intervene before health issues arise.
AI tool predicts childhood obesity with 80% accuracy
A groundbreaking AI-powered tool can now predict childhood obesity with high accuracy, offering early intervention opportunities to combat the growing health crisis.
NHS doctors accused of fat-shaming obese patients
A damning report exposes how overweight and obese patients are being fat-shamed by NHS doctors, leading to serious health consequences. Experts warn of the damaging effects of weight stigma in healthcare.
Weight-loss jabs linked to 5 deaths in Scotland
Five deaths in Scotland have been linked to popular weight-loss injections, prompting calls for an urgent safety review. Experts warn of potential risks as demand for these treatments soars.
Weight loss jabs transforming Gen X health
New research reveals that weight loss injections like Mounjaro and Wegovy are proving highly effective for Generation X, offering hope in the battle against obesity.
Weight Loss Jabs Could Be Banned in UK
Experts warn that two widely used weight loss injections may face restrictions in the UK due to safety concerns. Here’s the latest on the potential ban and alternatives.
NHS doctors strike again amid growing healthcare crisis
UK doctors are striking once more over pay and working conditions, deepening the NHS crisis. Here’s why they’re walking out and what it means for patients.
NHS to offer Wegovy and Mounjaro weight-loss drugs
The NHS is set to provide Wegovy and Mounjaro, groundbreaking weight-loss medications, following new evidence of their health benefits beyond obesity treatment.
Page 4 of 4